{rfName}
In

Indexed in

License and use

Citations

Altmetrics

Analysis of institutional authors

Llorens Bellés, VíctorAuthorMesquida, MCorresponding AuthorAdan, AAuthor
Share
Publications
>
Editorial Material

In Response to: 'Deuter CM, Zierhut M, Igney-Oertel A, et al. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment'

Publicated to:Ocular Immunology And Inflammation. 25 (2): 221-222 - 2017-04-01 25(2), DOI: 10.3109/09273948.2016.1145240

Authors: Mesquida, Marina; Llorenc, Victor; Adan, Alfredo

Affiliations

b Ophthalmology Clinical Research Unit , Fundacio Clinic per a la Recerca Biomedica, IDIBAPS , Barcelona , Spain - Author
a Institut Clinic d Oftalmologia, Hospital Clinic de Barcelona, Universitat de Barcelona , Barcelona Spain - Author
Agressió Biològica i Mecanismes de Resposta. Inflamació Ocular: Estudos Clínics i Experimentals. Institut d'Investigacions Biomèdiques August Pi i Sunyer - Author
Agressió Biològica i Mecanismes de Resposta. Malalties Autoimmunes Sistèmiques. Institut d'Investigacions Biomèdiques August Pi i Sunyer - Author
IDIBAPS, Ophthalmol Clin Res Unit, Fundacio Clin Recerca Biomed, Barcelona, Spain - Author
Univ Barcelona, Inst Clin Oftalmol, Hosp Clin Barcelona, Barcelona, Spain - Author
See more

Abstract

Keywords
Antibodies, monoclonal, humanizedHumansMacular edemaUveitis

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Ocular Immunology And Inflammation due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2017, it was in position 11/59, thus managing to position itself as a Q1 (Primer Cuartil), in the category Ophthalmology.

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-25:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 5 (PlumX).
Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Mesquida Febrer, Marina) and Last Author (Adán Civera, Alfredo).

the author responsible for correspondence tasks has been Mesquida Febrer, Marina.